Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03161847
Other study ID # 16-326
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date December 12, 2016
Est. completion date July 18, 2018

Study information

Verified date May 2017
Source University of New Mexico
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this study is to test a set of clinical outcome measures longitudinally in a cohort of OPMD patients to identify ones that show quantifiable change over time as the disease progresses. The investigators' goal is to delineate the natural history of OPMD.


Description:

OPMD patients will undergo a screening evaluation and testing to confirm the participants carry the OPMD mutation. Subjects fulfilling the inclusion/exclusion criteria will be enrolled and followed prospectively at regular intervals to determine the natural history of this disease. Measures of muscle function and swallowing will be made at baseline and at follow-up visits to measure natural clinical progression.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date July 18, 2018
Est. primary completion date July 18, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - OPMD by genetic criteria - = 18 years old - English-speaking Exclusion Criteria: - Another medical condition that precludes safe completion of study tasks (such as severe cardiac or respiratory disease) - Another medical condition that causes symptoms similar to OPMD (i.e., ptosis, dysphagia [trouble swallowing] or limb weakness). - History of head or neck cancer, or history of radiation to the head or neck - A videofluoroscopic swallow study within the 12 months prior to study enrollment

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Non-interventional study
Non-interventional study

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University of New Mexico University of Florida

Outcome

Type Measure Description Time frame Safety issue
Primary Muscle Strength over time Change in Manual muscle testing over time Baseline and every 9 months for 3 years
Secondary Dysphagia severity over time Videofluoroscopic Swallow Studies Baseline and every 9 months for 3 years
See also
  Status Clinical Trial Phase
Completed NCT02877784 - Screening in Oculopharyngeal Muscular Dystrophy
Recruiting NCT06185673 - A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia Phase 1/Phase 2
Enrolling by invitation NCT04009408 - Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders N/A
Recruiting NCT03874910 - Pathology Analysis of OPMD Patient Myotomies
Withdrawn NCT04226924 - Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose Phase 2
Recruiting NCT02158156 - Effect of Aerobic Training in Patients With Oculopharyngeal Muscular Dystrophy N/A
Completed NCT02015481 - Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients Phase 2